Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,185 | -33,158 | -21,997 | -8,591 | -21,214 |
| Depreciation Amortization | 216 | 121 | 46 | 21 | 707 |
| Accounts payable and accrued liabilities | -780 | -178 | 568 | 643 | -583 |
| Other Working Capital | 2,220 | 1,110 | 830 | 2,138 | 1,055 |
| Other Operating Activity | 14,162 | 9,798 | 6,345 | 92 | 4,100 |
| Operating Cash Flow | $-31,367 | $-22,307 | $-14,208 | $-5,697 | $-15,935 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -229 | -133 | -101 | -57 | -237 |
| Sale Of Investment | N/A | 6 | N/A | N/A | N/A |
| Other Investing Activity | -88 | -11 | 0 | 0 | 123 |
| Investing Cash Flow | $-317 | $-138 | $-101 | $-57 | $-114 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 2,500 |
| Common Stock Issued | 56,184 | 53,573 | 53,571 | N/A | 17,006 |
| Other Financing Activity | 0 | 103 | 97 | 0 | 18,444 |
| Financing Cash Flow | $56,184 | $53,676 | $53,668 | $0 | $37,950 |
| Exchange Rate Effect | N/A | N/A | 2 | -5 | N/A |
| Beginning Cash Position | 24,151 | 24,151 | 24,151 | 24,049 | 2,250 |
| End Cash Position | 48,651 | 55,382 | 63,512 | 18,290 | 24,151 |
| Net Cash Flow | $24,500 | $31,231 | $39,361 | $-5,759 | $21,901 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,367 | -22,307 | -14,208 | -5,697 | -15,935 |
| Capital Expenditure | -235 | -133 | -101 | -57 | -237 |
| Free Cash Flow | -31,602 | -22,440 | -14,309 | -5,754 | -16,172 |